|
Market Closed -
Nasdaq Stockholm
09:30:00 23/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5.600 SEK | +5.66% |
|
+3.70% | - |
| 05/10 | Mendus appoints board member chief operating officer | FW |
| 05/10 | Mendus AB Announces Management Changes, Effective October 05, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MENDUS AB | Other Biotechnology & Medical Research | +5.66% | +3.70% | 0.00% | -3.11% | -92.55% | 3.74Cr |  |  | |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
